Cell division and permeability of unbalanced envelope mutants of Escherichia coli K12.
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001692:Biological Transport; D002455:Cell Division; D002463:Cell Membrane Permeability; D002473:Cell Wall / Q000032:analysis / Q000502:physiology; D004261:DNA Replication; D012321:DNA-Directed RNA Polymerases; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D005840:Gentian Violet / Q000378:metabolism; D007700:Kinetics; D008070:Lipopolysaccharides / Q000032:analysis; D008962:Models, Theoretical; D009154:Mutation; D010405:Penicillinase / Q000378:metabolism; D010457:Peptidoglycan / Q000096:biosynthesis; D010641:Phenotype; D010743:Phospholipids / Q000032:analysis; D011506:Proteins / Q000032:analysis; D012293:Rifampin / Q000494:pharmacology; D014161:Transduction, Genetic
D000900:Anti-Bacterial Agents; D008070:Lipopolysaccharides; D010457:Peptidoglycan; D010743:Phospholipids; D011506:Proteins; D012321:DNA-Directed RNA Polymerases; D010405:Penicillinase; D005840:Gentian Violet; D012293:Rifampin